查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672958

痛风病治疗市场按药物类别、疾病类型、通路、给药途径和地区划分

Gout Disease Treatment Market, By Drug Class, By Disease Type, By Distribution Channel, By Route Of administration, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 182 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025年全球痛风病治疗市场规模估计为30.4亿美元，预计到2032年将达到53.2亿美元，2025年至2032年的复合年增长率为8.3%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 30.4亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 8.30％ 2032 年金额预测 53.2亿美元
数字。 2025 年痛风病治疗市场占有率（按地区划分）
痛风病治疗市场-IMG1

痛风病是一种常见的发炎性关节炎，由关节（通常是拇趾滑液囊炎）中尿酸结晶的堆积引起。痛风会导致一个或多个关节突然出现剧烈的疼痛、肿胀和压痛。已开发国家酒精消费量的增加、肥胖率和人口老化导致全球痛风盛行率上升。随着越来越多的治疗选择的出现以及人们对尿酸管理以预防痛风发作的认识的提高，全球痛风病治疗市场可能会成长。

市场动态

全球痛风病治疗市场的成长是由于全球老年人口的增加（他们更容易患上痛风）、肥胖率的上升导致痛风风险的增加，以及酒精和高嘌呤食物消费量的增加。此外，人们对早期诊断和治疗痛风以防止关节损伤的认识不断提高、新兴市场人均医疗支出的增加以及新产品的核准都是推动市场成长的一些因素。然而，Allopurinol的非专利竞争、药物副作用以及患者不依从性可能会阻碍市场的成长。具有新的治疗标靶和更佳安全性的在研药物的开发可以为市场参与企业提供丰厚的机会。

研究的主要特点

  • 本报告对全球痛风治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球痛风病治疗市场的主要企业概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球痛风病治疗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 透过全球痛风病治疗市场分析中使用的各种策略矩阵，相关人员将更容易做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球痛风治疗市场-冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球痛风病治疗市场（按药物类别划分）（十亿美元）

  • 介绍
  • NSAIDs
  • 皮质类固醇
  • 秋水仙碱
  • 降尿酸药物
  • 其他的

6. 2020-2032 年全球痛风病治疗市场（按疾病类型划分）（十亿美元）

  • 介绍
  • 急性痛风
  • 慢性痛风

7. 2020-2032 年全球痛风治疗市场按通路划分（十亿美元）

  • 介绍
  • 医院药房
  • 零售药局
  • 专业药房

8. 2020 年至 2032 年按给药途径分類的全球痛风病治疗市场（十亿美元）

  • 介绍
  • 口服
  • 肠外

9. 2020 年至 2032 年全球痛风病治疗市场（按地区划分）（十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • Takeda Pharmaceutical Company Ltd.
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • AstraZeneca plc
    • Horizon Therapeutics plc
    • Merck &Co. Inc.
    • Teijin Pharma Ltd.
    • GlaxoSmithKline, Plc.
    • Zydus Group
    • Menarini Group
    • JW Pharmaceutical
    • Simcere Pharmaceutical Group
    • Ionis Pharmaceuticals, Inc.
    • Selecta Biosciences
    • Mylan NV

第 11 章 分析师建议

  • 兴衰
  • 一致的机会地图

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI3082

Global Gout Disease Treatment Market is estimated to be valued at USD 3.04 Bn in 2025 and is expected to reach USD 5.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.30% 2032 Value Projection: USD 5.32 Bn
Figure. Gout Disease Treatment Market Share (%), By Region 2025
Gout Disease Treatment Market - IMG1

Gout disease is a common form of inflammatory arthritis that occurs when uric acid crystals accumulate in the joints, typically in the big toe. It causes sudden and severe attacks of pain, swelling and tenderness in one or more joints. Rising consumption of alcohol, obesity rates and aging populations in developed nations have contributed to increase in gout prevalence globally. Global gout disease treatment market can witness growth as more treatment options become available and awareness increases about managing uric acid levels to prevent gout flares.

Market Dynamics:

Global gout disease treatment market growth is driven by growing geriatric population globally who are more prone to develop gout, rising obesity rates leading to higher risk of gout, increasing consumption of alcohol and purine-rich foods. Moreover, growing awareness about early diagnosis and treatment of gout to prevent joint damage, rising per capita healthcare expenditure in developing countries and new product approvals can drive the market growth. However, generic competition for allopurinol, side effects of drugs and patient non-adherence can hamper the market growth. The development of novel treatment targets and pipeline drugs with improved safety profiles can provide lucrative opportunities for market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global gout disease treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global gout disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Takeda Pharmaceutical, Novartis, AstraZeneca, Teijin Pharma, Mylan, and Horizon Therapeutics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global gout disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gout disease treatment market

Detailed Segmentation-

  • By Drug Class
    • NSAIDs
    • Corticosteroids
    • Colchicine
    • Urate-Lowering Agents
    • Others
  • By Disease Type
    • Acute Gout
    • Chronic Gout
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Specialty Pharmacies
  • By Route Of administration
    • Oral
    • Parentral
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Takeda Pharmaceutical Company Ltd.
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • AstraZeneca plc
    • Horizon Therapeutics plc
    • Merck & Co. Inc.
    • Teijin Pharma Ltd.
    • GlaxoSmithKline, Plc.
    • Zydus Group
    • Menarini Group
    • JW Pharmaceutical
    • Simcere Pharmaceutical Group
    • Ionis Pharmaceuticals, Inc.
    • Selecta Biosciences
    • Mylan N.V.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Disease Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Gout Disease Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Gout Disease Treatment Market, By Drug Class, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • NSAIDs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Corticosteroids
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Colchicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urate-Lowering Agents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gout Disease Treatment Market, By Disease Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Acute Gout
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chronic Gout
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gout Disease Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gout Disease Treatment Market, By Route Of administration, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gout Disease Treatment Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USDBn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Takeda Pharmaceutical Company Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Horizon Therapeutics plc
    • Merck & Co. Inc.
    • Teijin Pharma Ltd.
    • GlaxoSmithKline, Plc.
    • Zydus Group
    • Menarini Group
    • JW Pharmaceutical
    • Simcere Pharmaceutical Group
    • Ionis Pharmaceuticals, Inc.
    • Selecta Biosciences
    • Mylan N.V.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact